E-Tag Syrup is a combination medication containing Terbutaline (1.25mg/5ml), Acebrophylline (50mg/5ml), and Guaifenesin (50mg/5ml), formulated to provide effective relief from respiratory conditions characterized by bronchospasm, mucus congestion, and cough. Terbutaline, a selective beta-2 adrenergic agonist, acts as a bronchodilator, relaxing the smooth muscles of the airways to ease breathing difficulties commonly associated with asthma, chronic bronchitis, and other obstructive airway diseases. Acebrophylline, a xanthine derivative, exhibits mucolytic and bronchodilatory properties, helping to reduce inflammation and facilitate the clearance of mucus from the respiratory tract. Guaifenesin serves as an expectorant, thinning and loosening mucus in the airways, thereby promoting productive cough and improving airway clearance. Together, these active ingredients work synergistically to alleviate symptoms such as wheezing, chest tightness, and persistent cough, enhancing respiratory function and patient comfort. E-Tag Syrup is typically prescribed for patients suffering from acute and chronic respiratory ailments where bronchospasm and mucus hypersecretion are prominent. It should be used under medical supervision, adhering to recommended dosages to minimize potential side effects such as tremors, palpitations, or gastrointestinal discomfort. This multi-action syrup offers a comprehensive approach to managing respiratory distress by targeting bronchial constriction, inflammation, and mucus buildup simultaneously.